1. Home
  2. FSP vs TIL Comparison

FSP vs TIL Comparison

Compare FSP & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.50

Market Cap

48.1M

Sector

Real Estate

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.38

Market Cap

48.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
TIL
Founded
1981
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
48.4M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
FSP
TIL
Price
$0.50
$7.38
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
284.9K
7.7K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
6.34%
N/A
EPS Growth
15.69
6.06
EPS
N/A
N/A
Revenue
$107,162,000.00
N/A
Revenue This Year
$17.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$5.67
52 Week High
$1.74
$33.83

Technical Indicators

Market Signals
Indicator
FSP
TIL
Relative Strength Index (RSI) 42.11 46.10
Support Level $0.43 $6.91
Resistance Level $0.52 $7.50
Average True Range (ATR) 0.03 0.19
MACD 0.00 0.03
Stochastic Oscillator 21.72 62.63

Price Performance

Historical Comparison
FSP
TIL

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: